Literature DB >> 18942112

Does cost-benefit analysis or self-control predict involvement in bullying behavior by male prisoners?

John Archer1, Natalie Southall.   

Abstract

The main aim of this study is to assess whether lack of self-control or the perceived costs and benefits of aggression provide the better predictors of bullying behavior and victimization, and direct aggression perpetration, in a sample of 122 male British prisoners. We also assessed whether bullying was associated with height and weight. Zero-order correlations showed that perceived benefits, self-control, and perceived costs were most closely associated with perpetration of bullying, and that lack of self-control was weakly associated with victimization. Height and weight were unrelated to bullying or victimization. In a standard regression analyses, perceived benefits was the strongest predictor of bullying perpetration, with lack of self-control contributing further; all three variables made a significant contribution when direct aggression was the criterion. Mediation analysis showed that a combined cost-benefit measure partially mediated the association between self-control and both bullying and direct aggression. The findings are discussed in relation to explanations of aggression based on impulse control or a cost-benefit analysis. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18942112     DOI: 10.1002/ab.20283

Source DB:  PubMed          Journal:  Aggress Behav        ISSN: 0096-140X            Impact factor:   2.917


  2 in total

1.  The brief self-control scale predicts jail inmates' recidivism, substance dependence, and post-release adjustment.

Authors:  Elizabeth T Malouf; Karen E Schaefer; Edward A Witt; Kelly E Moore; Jeffrey Stuewig; June P Tangney
Journal:  Pers Soc Psychol Bull       Date:  2013-12-17

Review 2.  A review of the role of cost-benefit analyses in 2-1-1 diffusion.

Authors:  Nancy Shank
Journal:  Am J Prev Med       Date:  2012-12       Impact factor: 5.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.